Publications
2025
Diep, D., de la Salle, S., Thibault Lévesque, J., Lifshitz, M., Garel, N., & Greenway, K. T. (2025). The ketamine chameleon: history, pharmacology, and the contested value of experience. Expert review of clinical pharmacology, 18(3), 109–129. https://doi.org/10.1080/17512433.2025.2459377
Adel, L., Moses, L., Irvine, E., Greenway, K. T., Dumas, G., & Lifshitz, M. (2025). A systematic review of hyperscanning in clinical encounters. Neuroscience & Biobehavioral Reviews, 176, 106248. https://doi.org/10.1016/j.neubiorev.2025.106248
Pronovost-Morgan, C., Greenway, K. T., Roseman, L., & The ReSPCT Experts. (2025). An international Delphi consensus for reporting of setting in psychedelic clinical trials. Nature Medicine, 31, 2186–2195. https://doi.org/10.1038/s41591-025-03685-9
Greenway, K. T., Garel, N., Dinh-Williams, L.-A. L., Thibault Lévesque, J., Kaelen, M., Dagenais-Beaulé, V., … Richard-Devantoy, S. (2025). The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression. The British Journal of Psychiatry, 1–9. https://doi.org/10.1192/bjp.2025.102
2024
de la Salle, S., Kettner, H., Thibault-Levesque, J., Garel, N., Dames, S., Patchett-Marble, R., Rej, S., Gloeckler, S., Erritzoe, D., Carhart-Harris, R., Greenway, K.T. (2024). Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy. Scientific Reports, 14(1), Article 16524. https://doi.org/10.1038/s41598-024-66817-0
Guay, É., Brouillette, M. J., Drury, J., Garel, N., & Greenway, K. (2024). Rapid Improvement of Post-Partum Depression With Subanesthetic Racemic Ketamine. Journal of clinical psychopharmacology, 44(2), 196–198. https://doi.org/10.1097/JCP.0000000000001780
Gloeckler, S. G., Lehmann, A., de la Salle, S., Greenway, K. T., & Lucas, P. (2024). Preferences and Attitudes Toward Music in Nonclinical Uses of Psychedelics. Psychedelic medicine, 2(4), 201–209. https://doi.org/10.1089/psymed.2024.0003
Greenway, K. T., Garel, N., Williams, L., Beaulieu, S., Turecki, G., Rej, S., & Richard-Devantoy, S. (2024). Music as an intervention to improve the hemodynamic response of ketamine in depression. JAMA Network Open, 7(2), e2354719. https://doi.org/10.1001/jamanetworkopen.2023.54719
Peill, J., Marguilho, M., Erritzoe, D., Barba, T., Greenway, K. T., Rosas, F., Timmerman, C., & Carhart-Harris, R. (2024). Psychedelics and the “inner healer”: Myth or mechanism? Journal of Psychopharmacology, 38(5), 417–424. https://doi.org/10.1177/02698811241239206
Gloecker, S. G., Thibault-Levesque, J., Lehmann, A., Farzin, H., & Greenway, K. T. (2024). Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence. Journal of Psychedelic Studies, 8(1), 45–56. https://doi.org/10.1556/2054.2024.00421
Erritzoe, D., Barba, T., Greenway, K. T., Murphy, R., Martell, J., Timmerman, C., Murphey-Beiner, A., Baker Jones, M., Nutt, D., Weiss, B., & Carhart-Harris, C. (2024). Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: Observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial. eClinicalMedicine, 76, 102799. https://doi.org/10.1016/j.eclinm.2024.102799
2023
Garel, N., Thibault-Levesque, J., Sandra, D., Solomonova, E., Lifshitz, M., Richard-Devantoy, S., & Greenway, K. T. (2023). Imprinting: Expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings. Frontiers in Human Neuroscience, 17, 1200393. https://doi.org/10.3389/fnhum.2023.1200393
La Torre, J. T., Mahammadli, M., Faber, S. C., Greenway, K. T., & Williams, M. T. (2023). Expert opinion on psychedelic-assisted psychotherapy for people with psychotic symptoms. International Journal of Mental Health and Addiction. Advance online publication. https://doi.org/10.21203/rs.3.rs-1241397/v1
Greenway, K. T. (2023). Context is critical for psychoactive drug effects. CNS Drugs, 37, 1065–1068. https://doi.org/10.1007/s40263-023-01053-0
Manson, E., Ryding, E., Taylor, W., Gloeckler, S. G., Allard, P., Johnny, C., Greenway, K. T., & Dames, S. (2023). Indigenous voices in psychedelic therapy: Experiential learnings from a community-based group psychedelic therapy program. Journal of Psychoactive Drugs, 5(23), 539–548. https://doi.org/10.1080/02791072.2023.2258120
Garel, N., Drury, J. L., Thibault-Levesque, J., Goyette, N., Lehmann, A., Looper, K., Erritzoe, D., Dames, S., Turecki, G., Rej, S., Richard-Devantoy, S., & Greenway, K. T. (2023). The Montreal Model: An integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression. Frontiers in Psychiatry, 14, 1268832. https://doi.org/10.3389/fpsyt.2023.1268832
Garel, N., Greenway, K. T., Dinh-Williams, L., Thibault-Levesque, J., Jutras-Aswad, D., Rej, S., & Richard-Devantoy, S. (2023). Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: A preliminary report. Neuropsychopharmacology, 48(12), 1769–1777. https://doi.org/10.1038/s41386-023-01689-y
Garel, N., Nazon, M., Naghi, K., Willis, E., Looper, K., Rej, S., & Greenway, K. T. (2023). Ketamine for depression: A potential role in requests for medical aid in dying. International Clinical Psychopharmacology, 38(1), 352–355. https://doi.org/10.1097/YIC.0000000000000483
2022
Gobbi, G., Inserra, A., Greenway, K. T., Lifshitz, M., & Kirmayer, L. J. (2022). Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice. Transcultural Psychiatry, 59(5), 718–724. https://doi.org/10.1177/13634615221098765
Garel, N., McAnulty, C., Greenway, K. T., Lesperance, P., Miron, J. P., Rej, S., Richard-Devantoy, S., & Jutras-Aswad, D. (2022). Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions. Drug and Alcohol Dependence, 239, 109606. https://doi.org/10.1016/j.drugalcdep.2022.109606
Houle, J., Schweitzer, L., & Greenway, K. T. (2022). Complex interaction of lithium with kidney and bone health. JAMA Psychiatry, 79(9), 936. https://doi.org/10.1001/jamapsychiatry.2022.12345
Damba, J. J., Bodenstein, K., Lavin, P., Drury, J., Sekhon, H., Renoux, C., Trinh, E., Rej, S., & Greenway, K. T. (2022). Psychotropic drugs and adverse kidney effects: A systematic review of the past decade of research. CNS Drugs, 36(10), 1049–1077. https://doi.org/10.1007/s40263-022-00912-3
Rosenblat, J. D., Husain, M. I., Lee, Y., McIntyre, R. S., Mansur, R. B., Castle, D., Offman, H., Parikh, S. V., Frey, B. N., Schaffer, A., Greenway, K. T., Garel, N., Beaulieu, S., Kennedy, S. H., Lam, R. W., Milev, R., Ravindran, A. V., Tourjman, V., Ameringen, M. V., & Yatham, L. N., Taylor, V. (2022). The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force report: Serotonergic psychedelic treatments for major depressive disorder. Canadian Journal of Psychiatry, 68, 5–21. https://doi.org/10.1177/07067437221111371
2021
Garel, N., Greenway, K. T., & Joober, R. (2021). The antipsychotic potential of cannabidiol: Clinical implications for patients with psychosis and comorbid cannabis substance use disorder. Journal of Psychiatry and Neuroscience, 46(1), E164–E165. https://doi.org/10.1503/jpn.210123
Richard-Devantoy, S., Badillo-Amberg, I., Greenway, K. T., Tomasso, M. D., Turecki, G., & Bertrand, J. A. (2021). Low MoCA performances correlate with suicidal ideation in late-life depression. Psychiatry Research, 301, 113957. https://doi.org/10.1016/j.psychres.2021.113957
Garel, N., Greenway, K. T., Tabbane, K., & Joober, R. (2021). Serotonin syndrome: SSRIs are not the only culprit. Journal of Psychiatry and Neuroscience, 46(3), E369–E370. https://doi.org/10.1503/jpn.210001
Greenway, K. T., Garel, N., Goyette, N., Turecki, G., & Richard-Devantoy, S. (2021). Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression. International Clinical Psychopharmacology, 36(4), 218–220. https://doi.org/10.1097/YIC.0000000000000356
2020
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020). Integrating psychotherapy and psychopharmacology: Psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology, 13(6), 655–670. https://doi.org/10.1080/17512433.2020.1783456
Richard-Devantoy, S., Bertrand, J. A., Béziat, S., Jaussent, I., Cazals, A., Ducasse, D., Greenway, K. T., Guillaume, S., Courtet, P., & Olié, E. (2021). Psychological pain and depression: it’s hard to speak when it hurts. International journal of psychiatry in clinical practice, 25(2), 180–186. https://doi.org/10.1080/13651501.2020.1836225
Duarte, D., Belzeaux, R., Etain, B., Greenway, K. T., Rancourt, E., Correa, H., Turecki, G., & Richard-Devantoy, S. (2020). Childhood-maltreatment subtypes in bipolar patients with suicidal behaviour: Systematic review and meta-analysis. Brazilian Journal of Psychiatry, 42(5), 558–567. https://doi.org/10.1590/1516-4446-2020-0015
2019
Richard-Devantoy, S., Orri, M., Bertrand, J. A., Greenway, K. T., Turecki, G., Gunnell, D., Power, C., & Geoffroy, M. C. (2019). Childhood cognitive skill trajectories and suicide by mid-adulthood: An investigation of the 1958 British Birth Cohort. Psychological Medicine, 49(18), 1–8. https://doi.org/10.1017/S0033291719001234